How Diversity In Therapeutic Strategies Is Expanding The Drug Discovery Toolbox
JN4123 Wuxi Therapeutic Strategies Article Final_HR_no_crops
Related Content
WuXi AppTec provides integrated and cost-effective services for: Polyclonal and monoclonal antibodies Anti-drug antibodies (ADA), host cell protein (HCP) antibodies,...
VIEW RESOURCEAntibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads, show great potential as cancer...
VIEW RESOURCE